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Abstract
Background: Colorectal cancer (CRC) screening rates are low in most Asian countries and remain largely unknown. 
This study examined trends in CRC screening rates after the introduction of the Korean National Cancer Screening 
Programme (NCSP) and determined the factors associated with uptake of CRC screening by test modality over time.
Methods: An annual population-based survey conducted through nationally representative random sampling from 
2005-2008. In total, 3,699 participants from the 2005-2008 surveys were selected as study subjects. Face-to-face 
interviews were performed to assess the utilization rate of CRC screening by each screening modality.
Results: Overall, CRC screening within the recommended time interval increased significantly from 22.9% in 2005 to 
36.6% in 2008 (p < 0.001). The proportion of subjects receiving a fecal occult blood test (FOBT) test within the previous 
year increased significantly from 7.2% in 2005 to 21.3% in 2008 (p < 0.001). Increases in FOBT testing were highest 
among those who had a lower income status (relative difference = 511.9%) and women (relative difference = 266.1%). 
Endoscopy use also increased from 18.0% in 2005 to 20.5% in 2008, albeit not significant. Overall, those who were male, 
non-smokers, 60-69 years old, and had a higher income status were more likely to have undergone up-to-date 
endoscopy and CRC screening.
Conclusions: This study revealed a substantial increase in up-to-date CRC screening in the general population from 
2005 to 2008. However, more than half of adults in Korea are still not up-to-date with their CRC tests. It will be 
important to continue to investigate factors associated with up-to-date CRC screening by each modality.
Background
Worldwide, colorectal cancer (CRC) is the fourth most
commonly diagnosed cancer in men and third in women
[1]. About 1 million new cases of CRC were diagnosed in
2002 (9.4% of all cancer diagnoses worldwide) [1]. How-
ever, at least a 25-fold variation in the occurrence of CRC
has been reported worldwide. Western countries have the
highest incidence rates [2]. Recently, CRC incidence rates
have been increasing rapidly in countries where the over-
all risk was once low (especially in Asia), whereas rates in
high-risk countries are either increasing gradually, stabi-
lizing (North and West Europe), or declining over time
(North America) [3]. In Korea, incidence rates have risen
markedly over the past few years (e.g., annual percent
change, APC = 7.3% per year between 1999 and 2005)
[4,5]. From 2003 to 2005, CRC was the third most com-
monly diagnosed cancer in Korea (12.0% of all cancer
diagnoses) [5].
Based on evidence that screening reduces CRC inci-
dence and mortality [6-9], national guidelines in several
countries now recommend regular CRC screening for
average-risk persons aged ≥50 years using one or more of
the following options: annual fecal occult blood test
(FOBT), flexible sigmoidscopy every 5 years, a combina-
tion of FOBT (or fecal immunochemical test) and flexible
sigmoidoscopy (FSIG), colonoscopy every 10 years, and/
or double-contrast barium enema (DCBE) every 5 years
[10,11]. Although the incidence of CRC is increasing rap-
idly in Asian countries, national guidelines for CRC
screening are nonexistent in most Asian countries [12].
Recently, the Asia Pacific Working Group on Colorectal
Cancer reached a consensus to develop guidelines for
CRC screening and recommend FOBT, FISG, and
colonoscopy as the best options [13].
In 2002, the National Cancer Center in Korea, and
Korean Society of Coloproctology developed guideline
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for CRC screening in average-risk adults [14]. This guide-
line recommends that average-risk adults begin screening
for CRC at age 50, having either (a) a colonoscopy every
5-10 years or (b) DCBE combined with FSIG every 5-10
years. In 2004, the Korean government also introduced
nationwide CRC screening as part of the National Cancer
Screening Programme (NCSP) for low-income groups.
Due to capacity related to performing colonoscopy
screenings on every age-eligible person, the NCSP pro-
vides an annual FOBT (immunochemical) test as the ini-
tial mass screening method for men and women ≥50
years instead of colonoscopy [15]. The NCSP provides
further investigation with a colonoscopy or DCBE for any
low-income individual with a positive FOBT result. In
2004, Medical Aid recipients and National Health Insur-
ance (NHI) beneficiaries within the lower 30% income
bracket were eligible for free-of-charge FOBT screening
services for CRC under NCSP. In 2005, the NCSP
e x p a n d e d  i t s  t a r g e t  p o p u l a t i o n  t o  t h e  5 0 %  i n c o m e
bracket. Apart from these organized CRC screening pro-
grammes, FOBT, DCBE, and colonoscopy testing are
conducted in outpatient clinics or private health-assess-
ment centers for opportunistic screening. However, in
these cases individuals must pay all procedure-related
costs.
Despite the evidence that screening can reduce the
incidence of and mortality from CRC, uptake of CRC
screening has been lower than for other mass cancer
screening interventions [16,17]. Globally, only half the eli-
gible population undergoes CRC screening [18-22]. In
particular, screening for CRC is not commonly practiced
in most Asian countries, and CRC screening behaviors in
Asian populations remains largely unknown. Although
national CRC screening programms have been offered
since 2004 in Korea, no studies have reported the extent
to which various CRC screening procedures have been
used by the general population. In addition, no studies
have analyzed whether usage of various types of screen-
ing procedures has changed over time since the introduc-
tion of the national CRC screening programme.
This study assessed the rates of CRC screening in Korea
by screening modalities using a population-based survey.
In particular, it examined trends in CRC screening rates
after the introduction of the NCSP using four indepen-
dent cross-sectional, nationally representative datasets
collected during 2005-2008, and identified the factors
associated with uptake of CRC screening by test modal-
ity.
Methods
Study Population
This study was based on the 2005, 2006, 2007, and 2008
Korean National Cancer Screening Survey (KNCSS). The
KNCSS is an annual cross-sectional survey that uses a
nationally representative random sampling to investigate
Korean participation rates in cancer screening for five
common cancers: gastric, liver, colorectal, breast, and
cervical [23]. In each study year, women aged ≥30 years
old and men aged ≥40 years old were selected from the
Resident of Registration Population data of the Korea
National Statistical Office using a stratified, multistage,
and random sampling procedure according to geographic
area, age, and gender. Face-to-face interviews were per-
formed.
In 2005, a total of 2,052 men (aged ≥40 years) and
women (aged ≥30 years) completed the interview
(response rate, 40.0%); in 2006, 2,033 (response rate,
43.4%), in 2007, 2,022 (response rate, 47.3%), and in 2008,
2,038 subjects (response rate, 47.6%) completed the inter-
view (Figure 1). Of the respondents, this study analyzed
data from cancer-free male and female subjects aged ≥50
years, the NCSP's recommended starting age for CRC
screening among persons at average risk [15]. Further,
respondents (n = 42) who had undergone CRC screening
because of a health problem or as a follow-up to a previ-
ously identified colorectal problem were excluded from
the analysis since the focus of the study is on routine
screening. In total, 3,699 participants from the 2005-2008
surveys were selected as study subjects. This study was
approved by the institutional review board of the
National Cancer Center, Korea.
Measures
Questions were developed to assess the utilization rate of
CRC screening by each screening modality. Questions
were prefaced with a two-to-three-sentence description
of the tests to help respondents differentiate among the
tests. The following main distinguishing characteristics of
the tests were provided: (a) FOBT is a test to find blood
using your stool sample. This test may use a special kit at
home or container to store your stool and send it to a
medical center; (b) endoscopy (e.g., sigmoidoscopy and
c o l o n o s c o p y )  i s  p e r f o r m e d  w i t h  a  fl e x i b l e  t u b e  p a s s e d
through the anus (we did not distinguish between
colonoscopy and sigmoidoscopy because lay people usu-
ally do not differentiate between these two tests.); (c)
DCBE is a radiological exam that looks for polyps or can-
cer in the colon or rectum. During this procedure, a phy-
sician administers a liquid with barium through the anus
and into the rectum and colon and takes x-rays.
Previous CRC screening experience was assessed by
asking respondents: (a) whether they had ever been
screened for CRC, (b) when they underwent their most
recent screening, and (c) which tests they underwent dur-
ing their most recent CRC screening (FOBT, endoscopy,
or DCBE). A respondent was considered to be "up-to-
date" if he or she had undergone an FOBT test within theChoi et al. BMC Public Health 2010, 10:265
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past 1 year, an endoscopy test within the past 10 years, or
a DCBE test within the past 5 years.
This survey also included demographic and socioeco-
nomic factors (e.g., gender, age, education, and household
income) associated with the uptake of CRC screening.
Household income was categorized into three groups
based on monthly post-tax household income (US$1 =
1000 won). We also included questions about health
insurance status. In Korea, every citizen, with the excep-
tion of some medical aid beneficiaries, is insured by the
NHI programme. Thus, subjects were classified as "NHI
beneficiary" or as "medical aid beneficiary." With regard
to health behavior, we ascertained smoking status. Sub-
jects were classified as current smokers if they reported
current smoking for at least 1 year or as non-smokers if
they had never smoked or had previously smoked but had
not smoked for at least the past 1 year. Health status was
measured by self-report; respondents rated their general
health status on a five-point scale (1 = very poor, 5 =
excellent).
Statistical analysis
Descriptive statistics were computed for all socioeco-
nomic factors and health behaviors. We calculated CRC
screening rates from 2005 to 2008 for each screening
method. First, we weighted samples by the appropriate
weight based on age and gender from the 2005 Korean
standard population [24]. Age- and gender-adjusted
logistic regression models were used to assess the odds of
having CRC screening by FOBT, endoscopy, and any test
within the guidelines. Further trends were examined
using the Cochran-Armitage trend test.
Changes in CRC testing between 2005 and 2008 were
assessed by comparing the rates from 2005 with the rates
in 2008 as relative risks. These risks are reported as the
percentage changes ([relative risk - 1] × 100) in rates
between the two years. Percentages were compared using
Fisher's exact test.
Multivariate logistic regression was used to determine
the factors associated with CRC screening procedure use
by FOBT, endoscopy, any test within guidelines. Initially,
separate models were tested for each outcome from the
2005-2008 survey samples, followed by models that
included all the samples with time as an indicator vari-
able. Because the results were similar when using sepa-
r a t e  m o d e l s  v e r s u s  o n e ,  w e  f o c u s e d  t h e  a n a l y s e s  o n
combined models. We did not include health insurance
type as a variable in the final multivariate model because
of its strong correlation with monthly household income.
To maintain a family α of 0.05 for the analyses of the 3
outcomes, we employed a Bonferroni adjustment using α
= 0.05/3 = 0.017. All statistical analyses were conducted
Figure 1 Participant selection process.
8,145 subjects with  no previous cancer 
diagnosis underwent interview survey 
2005 (n=2,052, 40.0%); 2006 (n=2,033, 43.3%)
2007 (n=2,022, 47.3%); 2008 (n=2,038, 47.6%)
Average response rate: 44.3%
3,699 subjects aged 50-79 yrs old men and 
women included final analysis 
2005 (n=927, 45.2%); 2006 (n=944, 46.4%);
2007 (n=906, 44.8%); 2008 (n=922, 45.2%)
Study inclusion rate: 45.4%
18,374 subjects aged   30 yrs women and 
   40 yrs men 
2005 (n=5,131); 2006 (n=4,687)
2007 (n=4,275); 2008 (n=4,281)
Excluded (n=10,229) 
- Refused  to participate (n=6,100)
- Incomplete survey (n=1,147)
- Not meeting including criteria (n=2,982)
Excluded (n=4,446) 
- Men and women aged < 50 yrs and 
  80 yrs (n=4,299)
- Missing information for income (n=105) 
- Respondents who had undergone CRC 
screening because of a health problem 
(n=42)Choi et al. BMC Public Health 2010, 10:265
http://www.biomedcentral.com/1471-2458/10/265
Page 4 of 9
using SAS statistical software (version 9.1; SAS Institute
Inc., Cary, NC).
Results
Table 1 presents descriptive data about the study partici-
pants. The demographic distribution of the sample was
almost homogenous among survey years, with the excep-
tion of household income and health insurance status. A
larger proportion of 2008 survey respondents reported
higher income compared to 2005 survey respondents.
Table 2 presents the proportion of subjects who
reported CRC testing. The proportion reporting FOBT
testing within the previous year increased significantly
from 7.2% in 2005 to 21.3% in 2008 (p < 0.001). Rates of
endoscopy use also increased from 18.0% in 2005 to
20.5% in 2008, albeit not significant (p = 0.060). Overall,
CRC screening within the recommended time interval
increased significantly from 22.9% in 2005 to 36.6% in
2008 (p < 0.001).
Tables 3 show changes in FOBT and endoscopy uses
between 2005 and 2008, comparing 2005 rates with 2008
rates as relative risks. The results indicate an increased
proportion of FOBT use from 2005 to 2008 in all study
population. In particular, increases in FOBT testing were
highest among those with lower income status (relative
difference percentage = 511.9%) and women (relative dif-
ference percentage = 266.1%).
The results from the full logistic regression models for
FOBT (model 1), endoscopy (model 2), and any test
(model 3) are shown in Table 4. Rates of FOBT testing
and any CRC testing were significantly increased in 2008
compared to 2005 at the adjusted α of 0.017. With regard
FOBT test, those who aged 60-69 years, and reported
their health status as "excellent/very good" were more
likely to have undergone FOBT testing. Endoscopies were
Table 1: Characteristics of respondents, 2005-2008 (n = 3,699)
2005 (n = 927) 2006 (n = 944) 2007 (n = 906) 2008 (n = 922) P value
%%%%
Gender
Male 46.8 46.9 47.1 47.3 0.997
Female 53.2 53.1 52.9 52.7
Age (years)
50-59 47.8 48.4 48.8 49.3 0.972
60-69 33.6 32.6 31.8 31.3
70-79 18.6 19.0 19.4 19.4
Education (level)
Did not complete high school 62.9 63.1 60.3 59.1 0.153
High school graduate or above 37.1 36.4 39.7 40.9
Monthly household income (US$)
Less than 1,500 24.7 27.1 21.4 20.9 0.002
1,500-3,000 55.1 48.6 52.1 51.2
3,000 or more 20.2 24.3 26.5 27.9
Health insurance type
Medical aid 5.1 7.8 4.1 5.3 0.005
National Health Insurance 94.9 92.2 95.9 94.7
Self-reported health status
Fair/poor 16.8 15.8 15.2 12.7 0.277
Good 28.7 28.0 27.8 28.3
Excellent/very good 54.5 56.2 57.0 59.0
Smoking status
Never smoked 23.9 23.1 22.7 20.3 0.391
Former smoker 14.8 13.1 14.6 16.1
Current smoker 61.3 63.8 62.7 63.6Choi et al. BMC Public Health 2010, 10:265
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significantly more likely among those aged 60-69 years,
those with higher income, and non-smokers. Women
were significantly less likely to have had an endoscopy
test. Overall, male, individuals aged 60-69 years, those
with higher income, and non-smokers were more likely to
have undergone up-to-date CRC screening.
Discussion
Early detection and treatment is an important way to
reduce mortality from colorectal cancer. Nonetheless,
Asians tend to have little understanding about CRC
screening. This report is the first to assess CRC screening
rates by various screening methods in a Korean popula-
tion at average risk for the disease. Data from national
surveys reveal that CRC screening remains underused in
Korea: in 2008, only 36.6% of the Korean population aged
≥50 years had undergone CRC screening within the rec-
ommended time interval. In contrast, data from the
National Health Interview Survey indicate that in the
United States, 44% of adults aged 50 to 64 years had
undergone a recommended CRC screening test in 2005
[25].
However, the current analysis revealed a substantial
increase in up-to-date CRC screening in the general pop-
ulation from 2005 to 2008. In addition, it showed sub-
stantial changes in the proportion of the general
population being screened by different screening modali-
ties. In 2005, only 23% of the Korean population was
screened by FOBT, endoscopy (colonoscopy and/or sig-
moidoscopy), and/or DCBE within guidelines. Screening
rates did increase over the 3-year period, yet by 2008 still
only 36.6% of respondents had been screened by 'any test'
within guidelines. The majority of this increase was
explained by a 14% increase in screening FOBT, yet there
was only a 2.5% increase in endoscopy. Although endos-
copy testing increased only slightly between 2005 and
2008 (relative difference percentage = 14%), FOBT testing
rates increased relatively more during the same period
(relative difference percentage = 196%). By 2008, FOBT
had become the most common CRC screening test
modality. In contrast, in the United States the prevalence
of CRC screening using endoscopy was more than twice
that using FOBT [25].
The large increases in FOBT use can be explained in
part by health care policy and public a wareness. Since
2004, the Korean government and NHIC have provided
free-of-charge annual FOBT testing as an initial screen-
ing tool for low-income individuals. The current analysis
revealed that the greatest increases in FOBT use were
among individuals with low household income (relative
difference percent = 512%). Further, FOBT testing
increased 266% among women from 2005 to 2008. These
results suggest that the substantial increase in FOBT test-
ing among women and low-income groups might have
been associated with the introduction of the NCSP. The
current analysis also revealed that endoscopy screening
rates increased slightly from 2005 to 2008. These rela-
tively small increases in endoscopy use can be attributed
in part to the fact that the NHI only reimburses colonos-
copy and sigmoidscopy testing for those with symptoms
or colorectal problems. Other health or educational poli-
cies, e.g., mass-media campaigns might have impacted on
the increment of the CRC screening rates.
Consistent with previously published literature regard-
ing CRC screening, we have shown that test use varies by
gender, age, income, smoking status [16,18-22]. Interest-
ingly, respondents with higher income levels were more
likely to have an endoscopy test. Under the Korean health
Table 2: Colorectal cancer screening rates in 2004, 2005, 2006, and 2008.
FOBT within previous year Endoscopya within previous 10
years
Any testb within recommended time interval
Percent OR (95% CI)c Percent OR (95% CI)c Percent OR (95% CI)c
2005 7.2 1.00 (referent) 18.0 1.00 (referent) 22.9 1.00 (referent)
2006 13.1 2.15 (1.57-2.96) 16.5 0.94 (0.74-1.19) 26.8 1.32 (1.07-1.64)
2007 17.5 3.03 (2.23-4.12) 18.0 1.06 (0.83-1.34) 29.0 1.46 (1.18-1.80)
2008 21.3 3.68 (2.72-4.97) 20.5 1.21 (0.96-1.53) 36.6 2.02 (1.64-2.48)
Ptrend
d <0.001 0.060 <0.001
a Flexible sigmoidoscopy or colonoscopy.
b Includes FOBT test within the past one year, endoscopy test within the past 10 years, or DCBE test within the past 5 years. The number 
screened does not equal the sum of participants because people may have had more than one test.
c Age and gender adjusted logistic regression models for each outcome were estimated.
d p-value for trend calculated using continuous values.C
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Table 3: Rate of up-to-date fecal occult blood test and endoscopy
FOBT within the previous year Endoscopya within the previous 10 years
2008 vs 2005 2008 vs 2005
2005 % 2008 % Relative
Difference
%b
Absolute Difference
percentage points
P valuec 2005 % 2008 % Relative
Difference
%b
Absolute
Difference
percentage
points
P valuec
Gender
Male 8.7 21.0 141.4 12.3 <0.001 18.2 19.3 6.0 1.1 0.756
Female 5.9 21.6 266.1 15.7 <0.001 17.8 21.6 21.3 3.8 0.156
Age (years)
50-59 6.4 19.4 203.1 13.0 <0.001 17.1 21.3 24.6 4.2 0.132
60-69 7.7 22.5 192.2 14.8 <0.001 19.9 21.5 8.0 1.6 0.675
70-79 8.4 24.0 185.7 15.6 <0.001 16.9 16.6 -1.8 -0.3 0.938
Education (level)
Did not complete high school 6.9 22.4 224.6 15.5 <0.001 17.7 19.6 10.7 1.9 0.449
High school graduate or above 7.7 19.7 155.8 12.0 <0.001 18.4 21.7 17.9 3.3 0.308
Monthly household income (US$)
Less than 1,500 4.2 25.7 511.9 21.5 <0.001 15.8 17.0 7.6 1.2 0.841
1,500-3,000 8.5 19.2 125.9 10.7 <0.001 17.1 18.9 10.5 1.8 0.516
3,000 or more 7.5 21.8 190.7 14.3 <0.001 22.9 26.0 13.5 3.1 0.521
Self-reported health status
Fair/poor 5.1 13.1 156.9 8.0 0.0184 17.1 17.9 4.7 0.8 0.987
Good 6.0 21.5 258.3 15.5 <0.001 18.2 24.4 34.1 6.2 0.104
Excellent/very good 8.5 23.0 170.6 14.5 <0.001 18.1 19.1 5.5 1.0 0.719
Smoking status
Current smoker 6.6 20.7 213.6 14.1 <0.001 15.2 19.3 27.0 4.1 0.346
Former smoker 6.7 22.1 229.9 15.4 <0.001 22.8 19.3 -15.4 -3.5 0.575
Never smoked 7.5 21.3 184.0 13.8 <0.001 17.9 21.1 17.9 3.2 0.183
a Flexible sigmoidoscopy or colonoscopy.
b The percentage changes ([relative risk - 1] × 100) in the rates between 2005 and 2008.
c All P values are two-sided and were calculated for exact comparisons of the rates between 2005 and 2008.Choi et al. BMC Public Health 2010, 10:265
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Table 4: Full Regression Models for Receipt of FOBT, Endoscopy, and Any test
Model 1: FOBT Model 2: Endsoscopya Model 3: Any testb
aOR 95% CI P aOR 95% CI P aOR 95% CI P
Gender
Male 1.00 Referent 1.00 Referent 1.00 Referent
Female 0.84 0.64 - 1.11 0.212 0.73 0.57 - 0.93 0.011 0.72 0.58 - 0.90 0.003
Age, y
50 - 59 1.00 Referent 1.00 Referent 1.00 Referent
60 - 69 1.38 1.12 - 1.70 0.003 1.45 1.20 - 1.76 0.001 1.49 1.26 - 1.75 <0.001
70 - 79 0.94 0.67 - 1.34 0.787 0.91 0.65 - 1.27 0.591 0.90 0.69 - 1.22 0.471
Education (years)
Did not complete 
high school
1.00 Referent 1.00 Referent 1.00 Referent
High school 
graduate or above
1.00 0.80 - 1.24 0.984 1.09 0.90- 1.33 0.390 1.03 0.87 - 1.22 0.727
Monthly household 
income (US$)
Less than 1,500 1.00 Referent 1.00 Referent 1.00 Referent
1,500 - 3,000 0.97 0.75 - 1.24 0.797 1.27 1.00 - 1.61 0.053 1.13 0.92 - 1.37 0.241
3,000 or more 1.11 0.83 - 1.49 0.489 1.81 1.37 - 2.38 <0.001 1.51 1.19 - 1.91 0.001
Self-reported health 
status
Fair/poor 1.00 Referent 1.00 Referent 1.00 Referent
Good 1.41 1.01 - 1.96 0.044 0.87 0.67 - 1.14 0.319 1.05 0.82 - 1.33 0.702
Excellent/very 
good
1.53 1.12 - 2.08 0.007 0.79 0.61 - 1.01 0.064 1.02 0.82 - 1.27 0.859
Smoking status
Current smoker 1.00 Referent 1.00 Referent 1.00 Referent
Former smoker 1.25 0.92 - 1.69 0.153 1.06 0.79 - 1.42 0.698 1.23 0.96 - 1.57 0.096
Never smoked 1.21 0.89 - 1.64 0.225 1.56 1.19 - 2.06 0.002 1.54 1.21 - 1.95 0.001
Time
2005 1.00 Referent 1.00 Referent 1.00 Referent
2006 2.13 1.55 - 2.93 <0.001 0.92 0.72 - 1.17 0.508 1.31 1.06 - 1.62 0.014
2007 2.98 2.19 - 4.06 <0.001 1.02 0.80 - 1.29 0.900 1.42 1.15 - 1.75 0.001
2008 3.57 2.64 - 4.83 <0.001 1.16 0.91 - 1.47 0.204 1.94 1.58 - 2.40 <0.001
-2 log likelihood 3005.931 3502.828 4375.334
a Flexible sigmoidoscopy and colonscopy.
b Includes FOBT and/or endoscopy. The number screened does not equal the sum of participants (i.e., people may have had > 1 test).
insurance system, an endoscopy test costs almost 10
times as much as an FOBT test. In addition, the NSCP
ensures free-of-charge FOBT testing for all individuals,
whereas endoscopy testing is only provided free of charge
for those whose FOBT results are positive. Furthermore,
the NHI only reimburses colonoscopy and sigmoidscopy
testing for those with symptoms or colorectal problems.
Therefore, endoscopy use varied with household income,
possibly suggesting that the cost of endoscopy is a barrier
to CRC screening.
We examined trends in screening for CRC by screening
modality and explored the factors associated with uptakeChoi et al. BMC Public Health 2010, 10:265
http://www.biomedcentral.com/1471-2458/10/265
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of CRC screening in a population sample. However, the
study's cross-sectional design and reliance on self-
reported screening limit the KNCSS. Previous studies
have indicated that self-reported FOBT screening data
might result in overestimates of the proportion screened
[26,27], and recent research has suggested that over-
reporting may be greater for FOBT than for endoscopy
[28]. Therefore, the proportion of subjects who were
actually up-to-date for CRC testing may be lower than
that indicated by the current analysis. Further, the cross-
sectional design of the study precludes conclusions about
whether any observed associations were causal. Finally,
our study sample may not be representative because of
low response rate. However, the KNCSS respondents had
health characteristics and behaviors that were very simi-
lar to those found in other extensively used surveys, such
as the Korea National Health and Nutrition Survey.
Conclusion
Our results demonstrate that CRC screening increased
after the introduction of the NCSP, according to a popu-
lation-based survey. Increasing recognition of the efficacy
and importance of CRC screening might have influenced
CRC screening rates. However, overall screening rates
increased less than did FOBT screening rates. The data
indicate increases in both FOBT and endoscopy testing
between 2005 and 2008, combined with a shift toward
greater use of FOBT compared with endoscopy. This shift
might be associated with national CRC screening poli-
cies. The introduction of free CRC screening appears to
have been effective in increasing CRC screening rates
among low-income groups in Korea. However, the
increases in FOBT test use have implications for public
health practice. Although FOBT is simple, safe, most
inexpensive, and its routine use was shown to reduce
CRC mortality, it is limited by poorer sensitivity, mainly
for premalignant lesions. Colonoscopy, on the other
hand, is a more accurate technique, yet invasive, carries a
risk of bleeding and perforation, requires preparation and
premedication, and involves much higher costs. The
options for CRC screening tests allow for flexibility but
can also render decisions about recommending or choos-
ing a particular test difficult. Each test has its tradeoffs in
terms of efficacy, complications, discomfort, time, and
cost [20]. More than half of adults in Korea are still not
up-to-date with their CRC tests. It will be important to
c o n t i n u e  t o  m o n i t o r  t r e n d s  i n  s cr ee n i n g,  as  w e l l  as  t o
investigate factors associated with up-to-date CRC
screening. More research will also be required to increase
CRC screening rates, particularly among those who had
not have CRC screening under NCSP.
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